Äèñêóññèîííûé Êëóá

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êàðäèîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé êàðäèîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #676  
Ñòàðûé 14.07.2013, 17:52
BMB BMB âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.10.2010
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 276
Ñêàçàë(à) ñïàñèáî: 113
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
BMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îñìåëþñü ïðåäïîëîæèòü, ÷òî äëÿ ïðèíÿòèÿ âçâåøåííîãî ðåøåíèÿ òóò íàäî çíàòü äëÿ äàííîé ãðóïïû ïàöèåíòîâ number needed to treat, number needed to harm, è ñòîèìîñòü quality-adjusted life year. Ê ñîæàëåíèþ, ýòî íå ìîé óðîâåíü, îáðàçîâàíèÿ ìàëîâàòî, ïîýòîìó áóêâîåäñòâóþ ñ ãàéäàìè. Íî ó÷èòûâàÿ õîðîøóþ ïåðåíîñèìîñòü ñòàòèíîâ è íàëè÷èå íåäîðîãèõ äæåíåðèêîâ ÿ íàäåþñü, ÷òî â öåëîì áàëàíñ îò íàçíà÷åíèÿ òàêèì ìîèì ïàöèåíòàì ñòàòèíîâ âñ¸-òàêè ïîëîæèòåëüíûé.
Îòâåòèòü ñ öèòèðîâàíèåì
  #677  
Ñòàðûé 14.07.2013, 18:08
khaertin khaertin âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 13.03.2006
Ãîðîä: Êàçàíü
Ñîîáùåíèé: 263
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 55 ðàç(à) çà 54 ñîîáùåíèé
khaertin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåkhaertin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåkhaertin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Áëÿøêà, êîòîðàÿ ìîæåò ðàçîðâàòüñÿ, ÷àùå âîîáùå íå áóäåò âûÿâëåíà íèêàêèìè ìåòîäàìè. Íî. åñëè ñëåäîâàòü Âàøåé ëîãèêå, òî íåîáõîäèìî áóäåò íàçíà÷àòü ñòàòèíû ïîæèçíåííî ñ äåòñàäîâñêîãî âîçðàñòà.
Îðèåíòèðóéòåñü íà SCORE.
Îòâåòèòü ñ öèòèðîâàíèåì
  #678  
Ñòàðûé 16.07.2013, 16:42
BMB BMB âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.10.2010
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 276
Ñêàçàë(à) ñïàñèáî: 113
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
BMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûå êîëëåãè, ó ìåíÿ íå âîïðîñ, à ïðîñüáà. Íå ìîãëè áû âû ìíå ïîìî÷ü äîáûòü Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ïîëíûé èëè executive summary) - ÷òîáû áûë è ñ îãëàâëåíèåì è îäíèì ôàéëîì. À òî âñ¸ ÷òî íàõîæó - ëèáî îäèí ôàéë áåç îãëàâëåíèÿ (î÷åíü íåóäîáíî èñêàòü íóæíîå), ëèáî êó÷åé îòäåëüíûõ ôàéëîâ (ïî 1 ôàéëó íà ãëàâó). Çàðàíåå áëàãîäàðåí.
Îòâåòèòü ñ öèòèðîâàíèåì
  #679  
Ñòàðûé 16.07.2013, 16:50
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò BMB Ïîñìîòðåòü ñîîáùåíèå
Óâàæàåìûå êîëëåãè, ó ìåíÿ íå âîïðîñ, à ïðîñüáà. Íå ìîãëè áû âû ìíå ïîìî÷ü äîáûòü Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ïîëíûé èëè executive summary) - ÷òîáû áûë è ñ îãëàâëåíèåì è îäíèì ôàéëîì. À òî âñ¸ ÷òî íàõîæó - ëèáî îäèí ôàéë áåç îãëàâëåíèÿ (î÷åíü íåóäîáíî èñêàòü íóæíîå), ëèáî êó÷åé îòäåëüíûõ ôàéëîâ (ïî 1 ôàéëó íà ãëàâó). Çàðàíåå áëàãîäàðåí.
Executive Summary Antithrombotic Therapy and Prevention of Thrombosis,
9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Âåñü
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #680  
Ñòàðûé 16.07.2013, 16:54
BMB BMB âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.10.2010
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 276
Ñêàçàë(à) ñïàñèáî: 113
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
BMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñïàñèáî, íî ýòè âàðèàíòû åñòü. Ex. summary - íåò îãëàâëåíèÿ, òîëüêî ìèíèàòþðû ñòðàíèö, íå ïîìîãàþùèå ïîèñêó. Ññûëêà íà âåñü - ýòî ïî îòäåëüíîìó ïäô-ôàéëó íà êàæäóþ ãëàâó. Íî âñ¸ ðàâíî ñïàñèáî Ëàäíî, êàê-íèáóäü òàê ïðèñïîñîáëþñü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #681  
Ñòàðûé 16.07.2013, 17:02
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò BMB Ïîñìîòðåòü ñîîáùåíèå
Ñïàñèáî, íî ýòè âàðèàíòû åñòü. Ex. summary - íåò îãëàâëåíèÿ, òîëüêî ìèíèàòþðû ñòðàíèö, íå ïîìîãàþùèå ïîèñêó. Ññûëêà íà âåñü - ýòî ïî îòäåëüíîìó ïäô-ôàéëó íà êàæäóþ ãëàâó. Íî âñ¸ ðàâíî ñïàñèáî Ëàäíî, êàê-íèáóäü òàê ïðèñïîñîáëþñü.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #682  
Ñòàðûé 16.07.2013, 17:09
BMB BMB âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.10.2010
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 276
Ñêàçàë(à) ñïàñèáî: 113
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
BMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Chevychelov Ïîñìîòðåòü ñîîáùåíèå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ýòî îäíà ãëàâà îòäåëüíûì ôàéëîì. Èçâèíèòå, ÷òî îçàäà÷èë. Âèäèìî â òîì âèäå, ÷òî ÿ "àë÷ó" ïðîñòî íåò â îòêðûòîì äîñòóïå. Íó, íèêòî íå îáåùàë, ÷òî áóäåò óäîáíî Åù¸ ðàç ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #683  
Ñòàðûé 22.07.2013, 09:03
vatt vatt âíå ôîðóìà ÂÐÀ×
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 11.08.2006
Ãîðîä: Ìûòèùè
Ñîîáùåíèé: 151
Ñêàçàë(à) ñïàñèáî: 36
Ïîáëàãîäàðèëè 14 ðàç(à) çà 14 ñîîáùåíèé
vatt ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Ïîäñêàæèòå ïîæàëóéñòà. Åñòü ïàöèåíòêà 87 ëåò, ïåðåíåñëà êðóïíîî÷àãîâûé èíôàðêò ïåðåäíåáîêîâîé ñ âåðõóøêîé â ìàå ýòîãî ãîäà, âûïèñàíà ñ ðåêîìåíäàöèÿìè êîðîíàðîãðàôèÿ-îïåðàöèÿ(íî îò ýòîãî îòêàç), ïðèíèìàëà òðîìáîàññ è êëîïèäîãðåëü 3 ìåñ, èìååò ïîñòîÿííóþ ôîðìó ÔÏ+ÕÑÍ 2Á. Êëîïèäîãðåëü îòìåíèëà â ñâÿçè ñ îêîí÷àíèåì ðåêîìåíäîâàííîãî ñðîêà-3 ìåñ.
Äóìàþ, îñòàâèòü åå íà òðîìáîàñå èëè âñå òàêè íàçíà÷èòü êñàðåëòî 15 ìã â ñóòêè ñ ó÷åòîì âîçðàñòà. ÌÍÎ êîíòðîëèðîâàòü íå ìîæåò. Ïåðåäâèãàåòñÿ â ïðåäåëàõ êâàðòèðû èç-çà îäûøêè, ñëàáîñòè. Èìååò òàêæå ëèìôîñòàç-ñëîíîâîñòü-ìíîãî ëåò. Ìàëîïîäâèæíà ñîîòâåñòâåííî. ÀÄ íèçêîå. Ïðèíèìàåò åùå äèãîêñèí, â áëîê, ëîçàï, âåðîøïèðîí, ôóðîñåìèä.
Îòâåòèòü ñ öèòèðîâàíèåì
  #684  
Ñòàðûé 22.07.2013, 10:57
Àâàòàð äëÿ Gilarov
Gilarov Gilarov âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 7,196
Ïîáëàãîäàðèëè 713 ðàç(à) çà 691 ñîîáùåíèé
Gilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äà, ðàçóìíî åå ïåðåâåñòè íà êñàðåëòî, îòìåíèâ àñïèðèí è êëîïè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #685  
Ñòàðûé 24.07.2013, 04:09
BMB BMB âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.10.2010
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 276
Ñêàçàë(à) ñïàñèáî: 113
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
BMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûå êîëëåãè, ïîäñêàæèòå - åñòü ëè ãäå-òî ïðàêòè÷åñêîå ðóêîâîäñòâî èëè ÷òî-òî ïîäîáíîå ïî ëå÷åíèþ õðîíè÷åñêîé ðåâìàòè÷åñêîé áîëåçíè ñåðäöà (íå ïîðîêà, à ñàìîé õðáñ). Èíòåðåñóåò - ÷òî, êðîìå ÑÎÝ íàäî ñìîòðåòü â ïëàíå àêòèâíîñòè ïðîöåññà, êîãäà íàçíà÷àòü ÍÏÂÏ, àíòèáèîòèêè (è íàçíà÷àòü ëè âîîáùå), ñêîëüêî ïðîäîëæàòü òàêîå ëå÷åíèå, êîìó ïðîâîäèòü áèöèëëèíîïðîôèëàêòèêó (è íàäî ëè âîîáùå?) Çàðàíåå ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #686  
Ñòàðûé 24.07.2013, 09:40
Shahla Shahla âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 10.04.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 1,732
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Shahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîñìîòðèòå ýòó òåìó.
http://forums.rusmedserv.com/showthr...E0%F2%E8%E7%EC
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà.
Òåðàïåâò, ïóëüìîíîëîã.
Îòâåòèòü ñ öèòèðîâàíèåì
  #687  
Ñòàðûé 24.07.2013, 12:43
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò BMB Ïîñìîòðåòü ñîîáùåíèå
Óâàæàåìûå êîëëåãè, ïîäñêàæèòå - åñòü ëè ãäå-òî ïðàêòè÷åñêîå ðóêîâîäñòâî èëè ÷òî-òî ïîäîáíîå ïî ëå÷åíèþ õðîíè÷åñêîé ðåâìàòè÷åñêîé áîëåçíè ñåðäöà (íå ïîðîêà, à ñàìîé õðáñ). Èíòåðåñóåò - ÷òî, êðîìå ÑÎÝ íàäî ñìîòðåòü â ïëàíå àêòèâíîñòè ïðîöåññà, êîãäà íàçíà÷àòü ÍÏÂÏ, àíòèáèîòèêè (è íàçíà÷àòü ëè âîîáùå), ñêîëüêî ïðîäîëæàòü òàêîå ëå÷åíèå, êîìó ïðîâîäèòü áèöèëëèíîïðîôèëàêòèêó (è íàäî ëè âîîáùå?) Çàðàíåå ñïàñèáî.
Ðóññêèé ïåðåâîä óñòàðåâøåé âåðñèè (ìîé) (ïóñòü Âàñ íå ïóãàåò íàçâàíèå, òàì åñòü è î ðåâìîêàðäèòå áåç ïîðîêà)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Ïîñëåäíÿÿ âåðñèÿ (2008, çäåñü ìîæíî ëåãêî ïîëó÷èòü ïåðåâîä â ãóãëüõðîìå)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Îðèãèíàë
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #688  
Ñòàðûé 26.07.2013, 17:22
Shahla Shahla âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 10.04.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 1,732
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Shahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûå êàðäèîëîãè, ïîìîãèòå ðàçîáðàòüñÿ. Âîïðîñ î ðåèíôàðêòå íà 5-å ñóòêè. Ðàçâå íà 5-å ñóòêè ãîâîðÿò î ðåèíôàðêòå?

Èñòî÷íèê: CASE FILES: Internal medicine third edition. Eugene C. Toy, John T.Patlan. Copyright © 2009.
A 59-year-old diabetic woman had suffered an acute anterior wall MI.Five days later, she gets into an argument with her husband and complains of chest pain. Her initial ECG shows no ischemic changes, but serum cardiac troponin I levels are drawn and return mildly elevated at this time. Which of the following is the best next step?
A. Thrombolytic therapy.
B. Percutaneous coronary intervention.
C. Coronary artery bypass.
D. Perform serial ECGs and obtain CK-MB.
E. Prepare the patient for dialysis.

ANSWER
D. Diabetic patients can have myocardial ischemia or infarction with atypical or absent symptoms. Clinical suspicion is required, and a liberal use of cardiac enzymes. Troponin levels often remain elevated for 7 to 10 days and should not be used to diagnose reinfarction, especially if the levels are trending downward. New ECG findings or rapidly rising markers such as serum myoglobin or CK-MB can be used in this setting.

ß íàøëà òîëüêî ýòó ñòàòüþ, http://medgazeta.rusmedserv.com/2003...ticle_305.html íî òàì î ñðîêàõ êîêðåòíî íå ãîâîðèòñÿ.
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà.
Òåðàïåâò, ïóëüìîíîëîã.
Îòâåòèòü ñ öèòèðîâàíèåì
  #689  
Ñòàðûé 26.07.2013, 17:52
BMB BMB âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.10.2010
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 276
Ñêàçàë(à) ñïàñèáî: 113
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
BMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBMB ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âîò ÷òî ïî ýòîìó ïîâîäó ñêàçàíî â [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Recurrent Myocardial Infarction:
‘Incident MI’ is defined as the individual’s first MI. When features of MI occur in the first 28 days after an incident event, this is not counted as a new event for epidemiological
purposes. If characteristics of MI occur after 28 days following an incident MI, it is considered to be a recurrent MI.
Reinfarction:
The term ‘reinfarction’ is used for an acute MI that occurs within 28 days of an incident- or recurrent MI.
Òî åñòü, íàñêîëüêî ÿ ïîíèìàþ recurrent ñîîòâåòñòâóåò íàøåìó "ïîâòîðíîìó" , à reinfarction - ðåöèäèâó ÈÌ

Êîììåíòàðèè ê ñîîáùåíèþ:
Shahla îäîáðèë(à): Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #690  
Ñòàðûé 26.07.2013, 17:53
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Shahla Ïîñìîòðåòü ñîîáùåíèå
Óâàæàåìûå êàðäèîëîãè, ïîìîãèòå ðàçîáðàòüñÿ. Âîïðîñ î ðåèíôàðêòå íà 5-å ñóòêè. Ðàçâå íà 5-å ñóòêè ãîâîðÿò î ðåèíôàðêòå?

Èñòî÷íèê: CASE FILES: Internal medicine third edition. Eugene C. Toy, John T.Patlan. Copyright © 2009.
A 59-year-old diabetic woman had suffered an acute anterior wall MI.Five days later, she gets into an argument with her husband and complains of chest pain. Her initial ECG shows no ischemic changes, but serum cardiac troponin I levels are drawn and return mildly elevated at this time. Which of the following is the best next step?
A. Thrombolytic therapy.
B. Percutaneous coronary intervention.
C. Coronary artery bypass.
D. Perform serial ECGs and obtain CK-MB.
E. Prepare the patient for dialysis.

ANSWER
D. Diabetic patients can have myocardial ischemia or infarction with atypical or absent symptoms. Clinical suspicion is required, and a liberal use of cardiac enzymes. Troponin levels often remain elevated for 7 to 10 days and should not be used to diagnose reinfarction, especially if the levels are trending downward. New ECG findings or rapidly rising markers such as serum myoglobin or CK-MB can be used in this setting.

ß íàøëà òîëüêî ýòó ñòàòüþ, http://medgazeta.rusmedserv.com/2003...ticle_305.html íî òàì î ñðîêàõ êîêðåòíî íå ãîâîðèòñÿ.
Âåðîÿòíî, ïðîáëåìà â òîì, ÷òî ñîâåòñêàÿ øêîëà âûäåëÿåò ðåöèäèâèðóùèé èíôàðêò è ïîâòîðíûé èíôàðêò. Â "çàïàäíîé" øêîëå òàêîãî ðàçäåëåíèÿ íåò
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
Shahla îäîáðèë(à): Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 14:45.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.